{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:42:25Z","timestamp":1790037745033,"version":"4.0.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2010,7,22]],"date-time":"2010-07-22T00:00:00Z","timestamp":1279756800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1007\/s11095-010-0203-x","type":"journal-article","created":{"date-parts":[[2010,7,21]],"date-time":"2010-07-21T21:51:46Z","timestamp":1279749106000},"page":"1987-1998","source":"Crossref","is-referenced-by-count":31,"title":["Evaluation of 99mTechnetium-Mebrofenin and 99mTechnetium-Sestamibi as Specific Probes for Hepatic Transport Protein Function in Rat and Human Hepatocytes"],"prefix":"10.1007","volume":"27","author":[{"given":"Brandon","family":"Swift","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim L. R.","family":"Brouwer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,7,22]]},"reference":[{"key":"203_CR1","first-page":"48","volume":"32","author":"E Doo","year":"1991","unstructured":"Doo E, Krishnamurthy GT, Eklem MJ, Gilbert S, Brown PH. Quantification of hepatobiliary function as an integral part of imaging with technetium-99m-mebrofenin in health and disease. J Nucl Med. 1991;32:48\u201357.","journal-title":"J Nucl Med."},{"key":"203_CR2","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0001-2998(05)80166-7","volume":"20","author":"GT Krishnamurthy","year":"1990","unstructured":"Krishnamurthy GT, Turner FE. Pharmacokinetics and clinical application of technetium 99m-labeled hepatobiliary agents. Semin Nucl Med. 1990;20:130\u201349.","journal-title":"Semin Nucl Med."},{"key":"203_CR3","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1007\/s11095-008-9597-0","volume":"25","author":"G Ghibellini","year":"2008","unstructured":"Ghibellini G, Leslie EM, Pollack GM, Brouwer KLR. Use of tc-99m mebrofenin as a clinical probe to assess altered hepatobiliary transport: integration of in vitro, pharmacokinetic modeling, and simulation studies. Pharm Res. 2008;25:1851\u201360.","journal-title":"Pharm Res."},{"key":"203_CR4","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.2967\/jnumed.109.062448","volume":"50","author":"KK Bhargava","year":"2009","unstructured":"Bhargava KK, Joseph B, Ananthanarayanan M, et al. Adenosine triphosphate-binding cassette subfamily C member 2 is the major transporter of the hepatobiliary imaging agent (99m)Tc-mebrofenin. J Nucl Med. 2009;50:1140\u20136.","journal-title":"J Nucl Med."},{"key":"203_CR5","first-page":"91","volume":"85","author":"T Pinos","year":"1990","unstructured":"Pinos T, Constansa JM, Palacin A, Figueras C. A new diagnostic approach to the Dubin-Johnson syndrome. Am J Gastroenterol. 1990;85:91\u20133.","journal-title":"Am J Gastroenterol."},{"key":"203_CR6","doi-asserted-by":"crossref","first-page":"5E","DOI":"10.1016\/0002-9149(90)90605-Z","volume":"66","author":"GA Beller","year":"1990","unstructured":"Beller GA, Sinusas AJ. Experimental studies of the physiologic properties of technetium-99m isonitriles. Am J Cardiol. 1990;66:5E\u20138E.","journal-title":"Am J Cardiol."},{"key":"203_CR7","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/00045415-200205000-00003","volume":"10","author":"S Mobasseri","year":"2002","unstructured":"Mobasseri S, Hendel RC. Cardiac imaging in women: use of radionuclide myocardial perfusion imaging and echocardiography for acute chest pain. Cardiol Rev. 2002;10:149\u201360.","journal-title":"Cardiol Rev."},{"key":"203_CR8","first-page":"977","volume":"53","author":"D Piwnica-Worms","year":"1993","unstructured":"Piwnica-Worms D, Chiu ML, Budding M, Kronauge JF, Kramer RA, Croop JM. Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex. Cancer Res. 1993;53:977\u201384.","journal-title":"Cancer Res."},{"key":"203_CR9","first-page":"369","volume":"38","author":"GD Luker","year":"1997","unstructured":"Luker GD, Fracasso PM, Dobkin J, Piwnica-Worms D. Modulation of the multidrug resistance P-glycoprotein: detection with technetium-99m-sestamibi in vivo. J Nucl Med. 1997;38:369\u201372.","journal-title":"J Nucl Med."},{"key":"203_CR10","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.clpt.2004.09.002","volume":"77","author":"M Wong","year":"2005","unstructured":"Wong M, Evans S, Rivory LP, et al. Hepatic technetium Tc 99m-labeled sestamibi elimination rate and ABCB1 (MDR1) genotype as indicators of ABCB1 (P-glycoprotein) activity in patients with cancer. Clin Pharmacol Ther. 2005;77:33\u201342.","journal-title":"Clin Pharmacol Ther."},{"key":"203_CR11","first-page":"545","volume":"3","author":"CC Chen","year":"1997","unstructured":"Chen CC, Meadows B, Regis J, et al. Detection of in vivo P-glycoprotein inhibition by PSC 833 using Tc-99m sestamibi. Clin Cancer Res. 1997;3:545\u201352.","journal-title":"Clin Cancer Res."},{"key":"203_CR12","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/009127001773744134","volume":"Suppl","author":"CA Slapak","year":"2001","unstructured":"Slapak CA, Dahlheimer J, Piwnica-Worms D. Reversal of multidrug resistance with LY335979: functional analysis of P-glycoprotein-mediated transport activity and its modulation in vivo. J Clin Pharmacol. 2001;Suppl:29\u201338.","journal-title":"J Clin Pharmacol."},{"key":"203_CR13","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/bjc.1998.57","volume":"77","author":"NH Hendrikse","year":"1998","unstructured":"Hendrikse NH, Franssen EJ, van der Graaf WT, et al. 99mTc-sestamibi is a substrate for P-glycoprotein and the multidrug resistance-associated protein. Br J Cancer. 1998;77:353\u20138.","journal-title":"Br J Cancer."},{"key":"203_CR14","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00280-004-0793-2","volume":"54","author":"NH Hendrikse","year":"2004","unstructured":"Hendrikse NH, Kuipers F, Meijer C, et al. In vivo imaging of hepatobiliary transport function mediated by multidrug resistance associated protein and P-glycoprotein. Cancer Chemother Pharmacol. 2004;54:131\u20138.","journal-title":"Cancer Chemother Pharmacol."},{"key":"203_CR15","doi-asserted-by":"crossref","first-page":"4228","DOI":"10.1200\/JCO.2005.04.8496","volume":"24","author":"M Michael","year":"2006","unstructured":"Michael M, Thompson M, Hicks RJ, et al. Relationship of hepatic functional imaging to irinotecan pharmacokinetics and genetic parameters of drug elimination. J Clin Oncol. 2006;24:4228\u201335.","journal-title":"J. Clin. Oncol."},{"key":"203_CR16","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1200\/JCO.2005.02.1295","volume":"24","author":"M Wong","year":"2006","unstructured":"Wong M, Balleine RL, Blair EY, et al. Predictors of vinorelbine pharmacokinetics and pharmacodynamics in patients with cancer. J Clin Oncol. 2006;24:2448\u201355.","journal-title":"J Clin Oncol."},{"key":"203_CR17","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/978-1-4899-1863-5_9","volume":"8","author":"EL LeCluyse","year":"1996","unstructured":"LeCluyse EL, Bullock PL, Parkinson A, Hochman JH. Cultured rat hepatocytes. Pharm Biotechnol. 1996;8:121\u201359.","journal-title":"Pharm Biotechnol."},{"key":"203_CR18","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1124\/jpet.106.119073","volume":"321","author":"EM Leslie","year":"2007","unstructured":"Leslie EM, Watkins PB, Kim RB, Brouwer KLR. Differential inhibition of rat and human Na+ -dependent taurocholate cotransporting polypeptide (NTCP\/SLC10A1)by bosentan: a mechanism for species differences in hepatotoxicity. J Pharmacol Exp Ther. 2007;321:1170\u20138.","journal-title":"J Pharmacol Exp Ther."},{"key":"203_CR19","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1515\/bchm2.1975.356.s1.827","volume":"356","author":"H Baur","year":"1975","unstructured":"Baur H, Kasperek S, Pfaff E. Criteria of viability of isolated liver cells. Hoppe Seylers Z Physiol Chem. 1975;356:827\u201338.","journal-title":"Hoppe Seylers Z Physiol Chem."},{"key":"203_CR20","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1124\/dmd.108.020842","volume":"36","author":"KK Wolf","year":"2008","unstructured":"Wolf KK, Brouwer KR, Pollack GM, Brouwer KLR. Effect of albumin on the biliary clearance of compounds in sandwich-cultured rat hepatocytes. Drug Metab Dispos. 2008;36:2086\u201392.","journal-title":"Drug Metab Dispos."},{"key":"203_CR21","first-page":"G12","volume":"277","author":"X Liu","year":"1999","unstructured":"Liu X, LeCluyse EL, Brouwer KR, et al. Biliary excretion in primary rat hepatocytes cultured in a collagen-sandwich configuration. Am J Physiol. 1999;277:G12\u201321.","journal-title":"Am J Physiol."},{"key":"203_CR22","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0091-679X(08)61797-5","volume":"13","author":"PO Seglen","year":"1976","unstructured":"Seglen PO. Preparation of isolated rat liver cells. Meth Cell Biol. 1976;13:29\u201383.","journal-title":"Meth Cell Biol."},{"key":"203_CR23","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1021\/mp800100e","volume":"6","author":"W Yue","year":"2009","unstructured":"Yue W, Abe K, Brouwer KLR. Knocking Down Breast Cancer Resistance Protein (Bcrp) by Adenoviral Vector-Mediated RNA Interference (RNAi) in Sandwich-Cultured Rat Hepatocytes: A novel tool to assess the contribution of bcrp to drug biliary excretion. Mol Pharm. 2009;6:134\u201343.","journal-title":"Mol Pharm."},{"key":"203_CR24","first-page":"G699","volume":"258","author":"RP Oude Elferink","year":"1990","unstructured":"Oude Elferink RP, Ottenhoff R, Liefting WG, Schoemaker B, Groen AK, Jansen PL. ATP-dependent efflux of GSSG and GS-conjugate from isolated rat hepatocytes. Am J Physiol. 1990;258:G699\u2013706.","journal-title":"Am J Physiol."},{"key":"203_CR25","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/BF01059769","volume":"21","author":"SD Studenberg","year":"1993","unstructured":"Studenberg SD, Brouwer KLR. Effect of phenobarbital and p-hydroxyphenobarbital glucuronide on acetaminophen metabolites in isolated rat hepatocytes: use of a kinetic model to examine the rates of formation and egress. J Pharmacokinet Biopharm. 1993;21:175\u201394.","journal-title":"J Pharmacokinet Biopharm."},{"key":"203_CR26","first-page":"G253","volume":"243","author":"K Tarao","year":"1982","unstructured":"Tarao K, Olinger EJ, Ostrow JD, Balistreri WF. Impaired bile acid efflux from hepatocytes isolated from the liver of rats with cholestasis. Am J Physiol. 1982;243:G253\u20138.","journal-title":"Am J Physiol."},{"key":"203_CR27","first-page":"43","volume":"26","author":"GM Groothuis","year":"1981","unstructured":"Groothuis GM, Hulstaert CE, Kalicharan D, Hardonk MJ. Plasma membrane specialization and intracellular polarity of freshly isolated rat hepatocytes. Eur J Cell Biol. 1981;26:43\u201351.","journal-title":"Eur J Cell Biol."},{"key":"203_CR28","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1080\/00498250400008363","volume":"34","author":"J Borlak","year":"2004","unstructured":"Borlak J, Klutcka T. Expression of basolateral and canalicular transporters in rat liver and cultures of primary hepatocytes. Xenobiotica. 2004;34:935\u201347.","journal-title":"Xenobiotica"},{"key":"203_CR29","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/S0006-2952(02)01382-5","volume":"64","author":"O Luttringer","year":"2002","unstructured":"Luttringer O, Theil FP, Lave T, Wernli-Kuratli K, Guentert TW, de Saizieu A. Influence of isolation procedure, extracellular matrix and dexamethasone on the regulation of membrane transporters gene expression in rat hepatocytes. Biochem Pharmacol. 2002;64:1637\u201350.","journal-title":"Biochem Pharmacol."},{"key":"203_CR30","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1083\/jcb.116.4.1043","volume":"116","author":"JC Dunn","year":"1992","unstructured":"Dunn JC, Tompkins RG, Yarmush ML. Hepatocytes in collagen sandwich: evidence for transcriptional and translational regulation. J Cell Biol. 1992;116:1043\u201353.","journal-title":"J Cell Biol."},{"key":"203_CR31","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1096\/fasebj.3.2.2914628","volume":"3","author":"JC Dunn","year":"1989","unstructured":"Dunn JC, Yarmush ML, Koebe HG, Tompkins RG. Hepatocyte function and extracellular matrix geometry: long-term culture in a sandwich configuration. FASEB J. 1989;3:174\u20137.","journal-title":"FASEB J."},{"key":"203_CR32","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1021\/bp00009a007","volume":"7","author":"JC Dunn","year":"1991","unstructured":"Dunn JC, Tompkins RG, Yarmush ML. Long-term in vitro function of adult hepatocytes in a collagen sandwich configuration. Biotechnol Prog. 1991;7:237\u201345.","journal-title":"Biotechnol Prog."},{"key":"203_CR33","doi-asserted-by":"crossref","first-page":"C1764","DOI":"10.1152\/ajpcell.1994.266.6.C1764","volume":"266","author":"EL LeCluyse","year":"1994","unstructured":"LeCluyse EL, Audus KL, Hochman JH. Formation of extensive canalicular networks by rat hepatocytes cultured in collagen-sandwich configuration. Am J Physiol. 1994;266:C1764\u201374.","journal-title":"Am J Physiol."},{"key":"203_CR34","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1023\/A:1011994831139","volume":"15","author":"X Liu","year":"1998","unstructured":"Liu X, Brouwer KLR, Gan LS, et al. Partial maintenance of taurocholate uptake by adult rat hepatocytes cultured in a collagen sandwich configuration. Pharm Res. 1998;15:1533\u20139.","journal-title":"Pharm Res."},{"key":"203_CR35","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1016\/S0022-3565(24)38310-7","volume":"289","author":"X Liu","year":"1999","unstructured":"Liu X, LeCluyse EL, Brouwer KR, Lightfoot RM, Lee JI, Brouwer KLR. Use of Ca2+ modulation to evaluate biliary excretion in sandwich-cultured rat hepatocytes. J Pharmacol Exp Ther. 1999;289:1592\u20139.","journal-title":"J Pharmacol Exp Ther."},{"key":"203_CR36","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0022-3565(25)21807-9","volume":"229","author":"WJ Brock","year":"1984","unstructured":"Brock WJ, Vore M. Characterization of uptake of steroid glucuronides into isolated male and female rat hepatocytes. J Pharmacol Exp Ther. 1984;229:175\u201381.","journal-title":"J Pharmacol Exp Ther."},{"key":"203_CR37","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2133\/dmpk.18.33","volume":"18","author":"Y Shitara","year":"2003","unstructured":"Shitara Y, Li AP, Kato Y, et al. Function of uptake transporters for taurocholate and estradiol 17beta-D-glucuronide in cryopreserved human hepatocytes. Drug Metab Pharmacokinet. 2003;18:33\u201341.","journal-title":"Drug Metab Pharmacokinet."},{"key":"203_CR38","doi-asserted-by":"crossref","first-page":"32599","DOI":"10.1074\/jbc.271.51.32599","volume":"271","author":"AE Busch","year":"1996","unstructured":"Busch AE, Quester S, Ulzheimer JC, et al. Electrogenic properties and substrate specificity of the polyspecific rat cation transporter rOCT1. J Biol Chem. 1996;271:32599\u2013604.","journal-title":"J Biol Chem."},{"key":"203_CR39","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0006-2952(00)00334-8","volume":"60","author":"R Chen","year":"2000","unstructured":"Chen R, Nelson JA. Role of organic cation transporters in the renal secretion of nucleosides. Biochem Pharmacol. 2000;60:215\u20139.","journal-title":"Biochem Pharmacol."},{"key":"203_CR40","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/372549a0","volume":"372","author":"D Grundemann","year":"1994","unstructured":"Grundemann D, Gorboulev V, Gambaryan S, Veyhl M, Koepsell H. Drug excretion mediated by a new prototype of polyspecific transporter. Nature. 1994;372:549\u201352.","journal-title":"Nature."},{"key":"203_CR41","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1211\/0022357055966","volume":"57","author":"Y Kobayashi","year":"2005","unstructured":"Kobayashi Y, Ohshiro N, Sakai R, Ohbayashi M, Kohyama N, Yamamoto T. Transport mechanism and substrate specificity of human organic anion transporter 2 (hOat2 [SLC22A7]). J Pharm Pharmacol. 2005;57:573\u20138.","journal-title":"J Pharm Pharmacol."},{"key":"203_CR42","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0014-5793(98)00585-7","volume":"429","author":"T Sekine","year":"1998","unstructured":"Sekine T, Cha SH, Tsuda M, et al. Identification of multispecific organic anion transporter 2 expressed predominantly in the liver. FEBS Lett. 1998;429:179\u201382.","journal-title":"FEBS Lett."},{"key":"203_CR43","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s004240100697","volume":"443","author":"V Cattori","year":"2001","unstructured":"Cattori V, van Montfoort JE, Stieger B, et al. Localization of organic anion transporting polypeptide 4 (Oatp4) in rat liver and comparison of its substrate specificity with Oatp1, Oatp2 and Oatp3. Pflugers Arch. 2001;443:188\u201395.","journal-title":"Pflugers Arch."},{"key":"203_CR44","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1097\/01.ASN.0000079040.55124.25","volume":"14","author":"NA Wolff","year":"2003","unstructured":"Wolff NA, Thies K, Kuhnke N, et al. Protein kinase C activation downregulates human organic anion transporter 1-mediated transport through carrier internalization. J Am Soc Nephrol. 2003;14:1959\u201368.","journal-title":"J Am Soc Nephrol."},{"key":"203_CR45","first-page":"1646","volume":"31","author":"ML Chiu","year":"1990","unstructured":"Chiu ML, Kronauge JF, Piwnica-Worms D. Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis (2-methoxyisobutylisonitrile) technetium(I) in cultured mouse fibroblasts. J Nucl Med. 1990;31:1646\u201353.","journal-title":"J Nucl Med."},{"key":"203_CR46","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1021\/mp900044x","volume":"6","author":"N Li","year":"2009","unstructured":"Li N, Bi YA, Duignan DB, Lai Y. Quantitative expression profile of hepatobiliary transporters in sandwich cultured rat and human hepatocytes. Mol Pharm. 2009;6:1180\u20139.","journal-title":"Mol Pharm."},{"key":"203_CR47","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1124\/jpet.104.081224","volume":"313","author":"K Letschert","year":"2005","unstructured":"Letschert K, Komatsu M, Hummel-Eisenbeiss J, Keppler D. Vectorial transport of the peptide CCK-8 by double-transfected MDCKII cells stably expressing the organic anion transporter OATP1B3 (OATP8) and the export pump ABCC2. J Pharmacol Exp Ther. 2005;313:549\u201356.","journal-title":"J Pharmacol Exp Ther."},{"key":"203_CR48","first-page":"1277","volume":"29","author":"PP Annaert","year":"2001","unstructured":"Annaert PP, Turncliff RZ, Booth CL, Thakker DR, Brouwer KLR. P-glycoprotein-mediated in vitro biliary excretion in sandwich-cultured rat hepatocytes. Drug Metab Dispos. 2001;29:1277\u201383.","journal-title":"Drug Metab Dispos."},{"key":"203_CR49","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0304-3835(99)00182-2","volume":"146","author":"M Bruin de","year":"1999","unstructured":"de Bruin M, Miyake K, Litman T, Robey R, Bates SE. Reversal of resistance by GF120918 in cell lines expressing the ABC half-transporter, MXR. Cancer Lett. 1999;146:117\u201326.","journal-title":"MXR Cancer Lett."},{"key":"203_CR50","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1124\/jpet.106.101840","volume":"319","author":"MJ Zamek-Gliszczynski","year":"2006","unstructured":"Zamek-Gliszczynski MJ, Hoffmaster KA, Humphreys JE, Tian X, Nezasa K, Brouwer KLR. Differential involvement of Mrp2 (Abcc2) and Bcrp (Abcg2) in biliary excretion of 4-methylumbelliferyl glucuronide and sulfate in the rat. J Pharmacol Exp Ther. 2006;319:459\u201367.","journal-title":"J Pharmacol Exp Ther."},{"key":"203_CR51","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/00006231-199504000-00156","volume":"16","author":"JR Ballinger","year":"1995","unstructured":"Ballinger JR, Hua HA, Berry BW, Firby P, Boxen I. 99Tcm-sestamibi as an agent for imaging P-glycoprotein-mediated multi-drug resistance: in vitro and in vivo studies in a rat breast tumour cell line and its doxorubicin-resistant variant. Nucl Med Commun. 1995;16:253\u20137.","journal-title":"Nucl Med Commun."},{"key":"203_CR52","first-page":"510","volume":"35","author":"VV Rao","year":"1994","unstructured":"Rao VV, Chiu ML, Kronauge JF, Piwnica-Worms D. Expression of recombinant human multidrug resistance P-glycoprotein in insect cells confers decreased accumulation of technetium-99m-sestamibi. J Nucl Med. 1994;35:510\u20135.","journal-title":"J Nucl Med."},{"key":"203_CR53","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1208\/aapsj060433","volume":"6","author":"G Ghibellini","year":"2004","unstructured":"Ghibellini G, Johnson BM, Kowalsky RJ, Heizer WD, Brouwer KLR. A novel method for the determination of biliary clearance in humans. AAPS J. 2004;6:e33.","journal-title":"AAPS J."},{"key":"203_CR54","first-page":"423","volume":"24","author":"AD Nunn","year":"1983","unstructured":"Nunn AD, Loberg MD, Conley RA. A structure-distribution-relationship approach leading to the development of Tc-99m mebrofenin: an improved cholescintigraphic agent. J Nucl Med. 1983;24:423\u201330.","journal-title":"J Nucl Med."},{"key":"203_CR55","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/sj.clpt.6100059","volume":"81","author":"G Ghibellini","year":"2007","unstructured":"Ghibellini G, Vasist LS, Leslie EM, et al. In vitro-in vivo correlation of hepatobiliary drug clearance in humans. Clin Pharmacol Ther. 2007;81:406\u201313.","journal-title":"Clin Pharmacol Ther."}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-010-0203-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11095-010-0203-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-010-0203-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T06:11:53Z","timestamp":1740291113000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11095-010-0203-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,22]]},"references-count":55,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["203"],"URL":"https:\/\/doi.org\/10.1007\/s11095-010-0203-x","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,22]]}}}